Opana ER Delayed Generics Antitrust Settlement

Impax Laboratories, Inc. is settling its part of an antitrust class action about an alleged conspiracy between itself and a group of Endo companies, including Endo Health Solutions, Inc., Endo Pharmaceuticals, Inc., and Penwest Pharmaceuticals Co. The complaint alleged that, in June 2010, Impax and Endo entered into a “pay for delay” agreement delaying the  Read more

Bottle of Opana ER

Syngenta, Corteva “Loyalty Programs” Restrict Competition Class Action

This antitrust class action bring suit against Syngenta Crop Protection AG, Syngenta Corporation, Syngenta Crop Protection, LLC, and Corteva, Inc., alleging that they have instituted “loyalty programs” for distributors of their pesticides containing certain ingredients. The complaint alleges that the real purpose and effect of these loyalty programs is to restrict the sale of competing  Read more

Growing Corn and Syngenta Name

Remicade Antitrust Settlement

Johnson & Johnson and Janssen Biotech, Inc. are putting up $25 million to settle an antitrust class action centering on anticompetitive actions they allegedly took to protect their drug Remicade (infliximab) from competition. The complaint alleged the companies violated federal and state antitrust laws and consumer protection laws by attempting to keep new entrants out  Read more

Remicade Box and Bottle

Syngenta, Corteva Anticompetitive “Loyalty Programs” Class Action

The pesticide industry is similar to the pharmaceutical industry in a number of ways, says the complaint for this class action: Both rely on patent protections, both have safety requirements, and in both, generics enter the market after patents have expired. But the complaint brings suit against pesticide companies Syngenta Crop Protection AG, Syngenta Corporation,  Read more

Syngenta Name Over Field of Crops

Bristol-Myers Squibb HIV cART Drugs Antitrust Direct Purchaser Partial Settlement

This is a partial settlement of an antitrust class action against Bristol-Myers Squibb Company, ER Squibb & Sons, LLC, and others. The complaints alleged that the companies violated antitrust laws by conspiring to extend patent protection for antiretroviral drugs for treating human immunodeficiency virus (HIV cART drugs) by engaging in anticompetitive conduct and restraining competition,  Read more

Evotaz Pills

Ranbaxy TPP Generic Nexium, Diovan, and Valcyte Settlement

Sun Pharmaceutical Industries, Ltd. and Ranbaxy, Inc. are settling combined class actions alleging generic drug manufacturer Ranbaxy made misrepresentations about both the conditions in its plants and the results of analyses on the integrity of data at the plants. This allowed it to obtain “tentative approval” from the Food and Drug Administration (FDA) and a  Read more

Sun Pharmaceuticals Sign at Building

Glumetza Antitrust Settlement

This settlement resolves an antitrust class action against a number of companies or groups of companies, including Bausch Health Companies, Inc., Salix Pharmaceuticals, Ltd., Depomed, Inc., and Assertio Therapeutics, Inc. The complaint alleged that the companies conspired to delay and impede the entry to the market of less expensive, generic versions of Glumetza, with Lupin  Read more

Pills and Capsules

Daraprim Third-Party Payors Settlement

This settlement resolves a class action on behalf of third-party payors who paid for or issued reimbursements for Daraprim. The complaint alleged that the defendants, Vyera Pharmaceuticals, LLC, Phoenixus AG, Martin Shkreli, and Kevin Mulleady violated antitrust laws with a scheme to thwart generic competition for the drug. A separate government action against Shkreli, a  Read more

Box of Daraprim Tablets

Restatis Eye Drops Antitrust Settlement

Allergan, Inc. is paying a penny less than $30 million to settle a class action alleging it schemed to retain a monopoly on its eye drop drug Restatis, and to keep consumers paying higher prices than necessary for it. The complaint alleged that it tried to keep generic versions off the market, submitted and obtained  Read more


Jazz Pharmaceuticals Anticompetitive Agreements on Xyrem Class Action

In recent years, we’ve seen a number of antitrust cases where a pharmaceutical company with a lucrative drug is accused of conspiring with generics companies to keep generic versions of that drug off the market. This class action alleges that Jazz Pharmaceuticals, related Jazz companies, and a long list of other drug companies conspired to  Read more

Dosing Process for Xyrem